Literature DB >> 28624413

SRSF3-regulated miR-132/212 controls cell migration and invasion by targeting YAP1.

Hye Ree Kim1, Su Jin Hwang1, Chang Hoon Shin1, Kyung Hee Choi1, Takbum Ohn2, Hyeon Ho Kim3.   

Abstract

Although SRSF3 (Serine/arginine-rich splicing factor 3) plays a significant role in various biological processes, many of its functions still remain unclear. More particularly, little is known about SRSF3's involvement in the regulation of miRNA. In this report, we found that invasive and migratory abilities were inhibited in SRSF3-silenced U2OS and HeLa cells. We also found that a knockdown of SRSF3 results in a decreased expression level of REST (RE1-silencing transcription factor). The silencing of REST increased the expression of primary miR-132/212 as well as their mature forms. In particular, miR-132-3p and miR-212-3p possess an identical seed sequences and a common target gene. Overexpression of miR-132-3p and miR-212-3p suppressed the expression of YAP1 (Yes-associated protein 1) by directly binding to the 3՚UTR of its mRNA. CCND1 (Cyclin D1), which acts downstream of YAP1, was downregulated in both miR-132-3p and miR-212-3p-overexpressed cells, in correlation with diminished YAP1 levels. Taken together, our results reveal that SRSF3 controls the expression of the miR-132/212 cluster through regulating REST expression, and that the REST-elicited alteration of miRNA expression is implicated in enabling the migratory and invasive abilities of cancer cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclin D1; MiR-132-3p; MiR-212-3p; REST; SRSF3; YAP1

Mesh:

Substances:

Year:  2017        PMID: 28624413     DOI: 10.1016/j.yexcr.2017.06.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis.

Authors:  Tuan-Mao Guo; Yong Yan; Wei-Ning Cao; Qiang Liu; Hai-Yun Zhu; Lan Yang; Mai-Cang Gao; Yan-Li Xing
Journal:  Clin Rheumatol       Date:  2018-03-01       Impact factor: 2.980

2.  Clinical significance of AJUBA, YAP1, and MMP14 expression in esophageal squamous cell carcinoma.

Authors:  Qing Zhang; Lei Lou; Xiaoli Cai; Zengfang Hao; Saisai Nie; Ying Liu; Lingrui Su; Wenxin Wu; Haitao Shen; Yuehong Li
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

3.  MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.

Authors:  Jian-Qing Chen; Yang-Liu Ou; Zhi-Ping Huang; Yong-Gang Hong; Yuan-Ping Tao; Zhen-Guang Wang; Jun-Sheng Ni; Li-Qiang Hao; Hui Lin
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

4.  Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells.

Authors:  Malgorzata Burek; Anna König; Mareike Lang; Jan Fiedler; Sabrina Oerter; Norbert Roewer; Michael Bohnert; Serge C Thal; Kinga G Blecharz-Lang; Johannes Woitzik; Thomas Thum; Carola Y Förster
Journal:  Transl Stroke Res       Date:  2019-01-08       Impact factor: 6.829

5.  Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.

Authors:  Jihua Guo; Xiaoxuan Che; Xiaole Wang; Rong Jia
Journal:  RSC Adv       Date:  2018-02-14       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.